BNO 0.00% 1.0¢ bionomics limited

Constant investor, page-2

  1. 264 Posts.
    lightbulb Created with Sketch. 12
    2 very positive analyst reports at the back of the results as well

    BELL POTTER

    22 September
    BNC210 Shines in Phase 2 GAD Trial, Partnering Prospects Strengthen
    Analyst: Tanushree Jain

    ROTH CAPITAL PARTNERS

    21 September 2016

    Whoomp There It Is! Looking Like a Paradigm Shift?
    Analyst: Joseph Pantginis
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.